The Future of Kidney Transplant Monitoring: Moving Beyond Biopsies - Sara Barrington, CEO of Verici Dx
In this episode of Diagnosing Dx, I’m joined by Sara Barrington, CEO at Verici Dx.
Sara explains how Verici Dx is tackling one of the biggest unresolved problems in kidney transplant care: helping clinicians monitor patients more precisely after transplant without relying so heavily on biopsies and legacy testing.
We explore why balancing rejection risk against unnecessary immunosuppression is so difficult, and how better molecular insight could support earlier, more accurate decisions.
We also discuss Verici Dx’s RNA sequencing and AI-driven approach, the decision to license one test to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.